Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May 16;21(10):3531.
doi: 10.3390/ijms21103531.

The Influence of Small Intestinal Bacterial Overgrowth in Digestive and Extra-Intestinal Disorders

Affiliations
Review

The Influence of Small Intestinal Bacterial Overgrowth in Digestive and Extra-Intestinal Disorders

Giuseppe Losurdo et al. Int J Mol Sci. .

Abstract

Small intestinal bacterial overgrowth (SIBO) is a condition hallmarked by an increase in the concentration of colonic-type bacteria in the small bowel. Watery diarrhea, bloating, abdominal pain and distension are the most common clinical manifestations. Additionally, malnutrition and vitamin (B12, D, A, and E) as well as minerals (iron and calcium) deficiency may be present. SIBO may mask or worsen the history of some diseases (celiac disease, irritable bowel disease), may be more common in some extra-intestinal disorders (scleroderma, obesity), or could even represent a pathogenetic link with some diseases, in which a perturbation of intestinal microbiota may be involved. On these bases, we performed a review to explore the multiple links between SIBO and digestive and extra-intestinal diseases.

Keywords: Parkinson disease; inflammatory bowel disease; irritable bowel syndrome; microbiota; obesity; rheumatology; skin diseases; small intestinal bacterial overgrowth.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Stepwise approach to non-responsive celiac disease and the importance of SIBO recognition in this process.
Figure 2
Figure 2
Role of SIBO and gut microbiota in the pathogenesis of hepatic encephalopathy. Both SIBO and a dysbiosis with low Bacteroidetes and high Proteobacteria and Fusobacteria may contribute to the pathogenesis of HE, by engendering a damage to tight junctions and producing toxins and ammonia which, in turn, worsen HE.

References

    1. Bures J., Cyrany J., Kohoutova D., Förstl M., Rejchrt S., Kvetina J., Vorisek V., Kopacova M. Small intestinal bacterial overgrowth syndrome. World J. Gastroenterol. 2010;16:2978–2990. doi: 10.3748/wjg.v16.i24.2978. - DOI - PMC - PubMed
    1. Husebye E. The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy. 2005;51(Suppl. 1):1–22. doi: 10.1159/000081988. - DOI - PubMed
    1. Gibiino G., Ianiro G., Cammarota G., Gasbarrini A. The gut microbiota: Its anatomy and physiology over a lifetime. Minerva Gastroenterol. Dietol. 2017;63:329–336. - PubMed
    1. Rezaie A., Pimentel M., Rao S.S. How to test and treat small intestinal bacterial overgrowth: An evidence-based approach. Curr. Gastroenterol. Rep. 2016;18:8. doi: 10.1007/s11894-015-0482-9. - DOI - PubMed
    1. Losurdo G., Leandro G., Ierardi E., Perri F., Barone M., Principi M., Di Leo A. Breath Tests for the Non-invasive Diagnosis of Small Intestinal Bacterial Overgrowth: A Systematic Review with Meta-analysis. J. Neurogastroenterol. Motil. 2020;26:16–28. doi: 10.5056/jnm19113. - DOI - PMC - PubMed

LinkOut - more resources